Drug intelligence / Profile preview

Re Depth 15

Development stage
Unknown
Lead developer
Austrak
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Re Depth 15 (also known as RE-Depth 15) is an oral prebiotic and probiotic supplement developed and marketed by Austrak. It is formulated as a capsule containing a combination of beneficial bacterial strains—specifically *Bifidobacterium longum* (5 billion spores), *Lactobacillus acidophilus* (5 billion spores), and *Streptococcus thermophilus* (5 billion spores)—along with the prebiotic fiber fructo-oligosaccharides (FOS) (100 mg). Positioned within Austrak's nephrology portfolio, Re Depth 15 is designed to support the gut-kidney axis by restoring a healthy balance of gut microbiota, which can help mitigate the accumulation of uremic toxins in patients with chronic kidney disease. Additionally, it is utilized to manage gastrointestinal dysbiosis, antibiotic-associated diarrhea, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).

Brand names
RE-Depth 15RE-Depth15RE-Depth-15RE-Depth 15 CapsuleRE-Depth15 CapsuleRE-Depth-15 CapsuleRe Depth 15
Other names
Bifidobacterium longum + fructo-oligosaccharides + Lactobacillus acidophilus + Streptococcus thermophilusRE-Depth 45RE-Depth45RE-Depth-45RE-Depth 90RE-Depth90RE-Depth-90Re Depth 45Re Depth 90

Beyond the preview

Go deeper on Re Depth 15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Re Depth 15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call